The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating 'trials within cohorts' (TwiCs) for the evaluation of interventions for prostate cancer.

MLA

Teunissen, Frederik R., et al. “The First Patient-Reported Outcomes from the Utrecht Prostate Cohort (UPC): The First Platform Facilitating ‘Trials within Cohorts’ (TwiCs) for the Evaluation of Interventions for Prostate Cancer.” World Journal of Urology, vol. 40, no. 9, Sept. 2022, pp. 2205–12. EBSCOhost, https://doi.org/10.1007/s00345-022-04092-2.

APA

Teunissen, F. R., Willigenburg, T., Meijer, R. P., van Melick, H. H. E., Verkooijen, H. M., & van der Voort van Zyp, J. R. N. (2022). The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating “trials within cohorts” (TwiCs) for the evaluation of interventions for prostate cancer. World Journal of Urology, 40(9), 2205–2212. https://doi.org/10.1007/s00345-022-04092-2

Chicago

Teunissen, Frederik R, Thomas Willigenburg, Richard P Meijer, Harm H E van Melick, Helena M Verkooijen, and Jochem R N van der Voort van Zyp. 2022. “The First Patient-Reported Outcomes from the Utrecht Prostate Cohort (UPC): The First Platform Facilitating ‘Trials within Cohorts’ (TwiCs) for the Evaluation of Interventions for Prostate Cancer.” World Journal of Urology 40 (9): 2205–12. doi:10.1007/s00345-022-04092-2.